| 1 | KIR2DL2, KIR2DS2
|
| Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.
|
| Salim PH, Jobim M, Bredemeier M, Chies JA, Schlottfeldt J, Brenol JC, Jobim LF, Xavier RM.
|
| Clin Exp Immunol lin Exp Immunol. 2010 Jan 15. [Epub ahead of print]PMID: 20082621 2010
|
| 2 | KIR2DL2
|
| Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand binding.
|
| Ramos-Lopez E, Scholten F, Aminkeng F, Wild C, Kalhes H, Seidl C, Tonn T, Van der Auwera B, Badenhoop K.
|
| Tissue Antigens 73(6):599-603. Epub 2009 Apr 8.PMID: 19392800 2009
|
| 3 | KIR2DL2, KIR2DL4
|
| DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors.
|
| Liu Y, Kuick R, Hanash S, Richardson B.
|
| Clin Immunol 130(2):213-24. Epub 2008 Oct 22.PMID: 18945643 2009
|
| 4 | KIR2DL1, KIR2DL2, KIR2DL3, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5, KIR3DS1
|
| Alternatively spliced forms of human killer inhibitory receptors.
|
| Dohring C, et al.
|
| Immunogenetics 44 : 227-230. 1996
|
| 5 | KIR2DL2, KIR2DL3, KIR2DL4, KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5
|
| Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
|
| Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L.
|
| J Exp Med 182 : 875-884. 1995
|